Iclusig (ponatinib) is a cancer medicine that interferes with the growth of some cancer cells.
Iclusig is used in adults to treat a type of blood cancer called chronic myeloid leukemia (CML), or Philadelphia chromosome positive acute lymphoblastic leukemia (ALL).
Iclusig is usually given after other similar medications have been tried without success.
